Decatur Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-76,425
Closed -$11M 93
2016
Q4
$11M Sell
76,425
-27,021
-26% -$3.62M 1.58% 37
2016
Q3
$13M Buy
103,446
+16,931
+20% +$2.19M 1.62% 37
2016
Q2
$11.4M Sell
86,515
-3,600
-4% -$493K 1.53% 42
2016
Q1
$12.5M Sell
90,115
-150
-0.2% -$20K 1.64% 40
2015
Q4
$12.6M Sell
90,265
-500
-0.6% -$68.9K 1.62% 36
2015
Q3
$12.7M Sell
90,765
-19,075
-17% -$2.87M 1.73% 29
2015
Q2
$18M Sell
109,840
-78,075
-42% -$12.5M 2.24% 13
2015
Q1
$29M Buy
187,915
+4,575
+2% +$651K 3.6% 1
2014
Q4
$23M Buy
183,340
+33,565
+22% +$4.15M 3.07% 1
2014
Q3
$17.9M Buy
149,775
+20,875
+16% +$2.39M 3.01% 1
2014
Q2
$13.9M Buy
128,900
+79,950
+163% +$8.24M 2.62% 1
2014
Q1
$4.87M Sell
48,950
-44,450
-48% -$4.02M 0.93% 47
2013
Q4
$8.63M Buy
93,400
+21,550
+30% +$1.91M 1.66% 17
2013
Q3
$6.01M Buy
+71,850
New +$6.16M 1.27% 36

Other funds holding ELV

Decatur Capital Management's ELV Position: Q1 2017 in Review

Decatur Capital Management sold out of Elevance Health (ELV) in Q1 2017, closing a stake of 76,425 shares — an estimated $11M sold.

Decatur Capital Management first reported a position in ELV in Q3 2013 and held it in 14 quarters. The position peaked at $29M in Q1 2015. 795 funds tracked by Wall St. Rank hold ELV as of Q1 2017.

  • Decatur Capital Management reported no remaining Elevance Health position as of Q1 2017 after selling out during the quarter.
  • Decatur Capital Management sold 76,425 Elevance Health shares in Q1 2017, an estimated $11M.
  • Decatur Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 14 quarters.
  • Decatur Capital Management's Elevance Health position peaked at $29M in Q1 2015.
  • 795 funds tracked by Wall St. Rank held Elevance Health as of Q1 2017.

Based on Decatur Capital Management's 13F filing for Q1 2017, filed 27 Apr 2017.